| アブストラクト | BACKGROUND: Distinguishing between mortality attributed to respiratory causes and other causes among people with asthma, COPD, and asthma-COPD overlap (ACO) is important. This study used electronic health records in England to estimate excess risk of death from respiratory-related causes after accounting for other causes of death. METHODS: We used linked Clinical Practice Research Datalink (CPRD) primary care and Office for National Statistics mortality data to identify adults with asthma and COPD from 2005 to 2015. Causes of death were ascertained using death certificates. Hazard ratios (HR) and excess risk of death were estimated using Fine-Gray competing risk models and adjusting for age, sex, smoking status, body mass index and socioeconomic status. RESULTS: 65,021 people with asthma and 45,649 with COPD in the CPRD dataset were frequency matched 5:1 with people without the disease on age, sex and general practice. Only 14 in 100,000 people with asthma are predicted to experience a respiratory-related death up to 10 years post-diagnosis, whereas in COPD this is 98 in 100,000. Asthma is associated with an 0.01% excess incidence of respiratory related mortality whereas COPD is associated with an 0.07% excess. Among people with asthma-COPD overlap (N = 22,145) we observed an increased risk of respiratory-related death compared to those with asthma alone (HR = 1.30; 95% CI 1.21-1.40) but not COPD alone (HR = 0.89; 95% CI 0.83-0.94). CONCLUSIONS: Asthma and COPD are associated with an increased risk of respiratory-related death after accounting for other causes; however, diagnosis of COPD carries a much higher probability. ACO is associated with a lower risk compared to COPD alone but higher risk compared to asthma alone. |
|---|
| ジャーナル名 | BMC pulmonary medicine |
|---|
| Pubmed追加日 | 2022/1/10 |
|---|
| 投稿者 | Gayle, Alicia V; Minelli, Cosetta; Quint, Jennifer K |
|---|
| 組織名 | National Heart and Lung Institute, Imperial College London, G08 Emmanuel Kaye;Building, Manresa Road, London, SW3 6LR, UK. alicia.gayle14@imperial.ac.uk.;Imperial Biomedical Research Center, National Institute for Health Research,;London, UK. alicia.gayle14@imperial.ac.uk.;AstraZeneca PLC, Cambridge, UK. alicia.gayle14@imperial.ac.uk.;Building, Manresa Road, London, SW3 6LR, UK.;London, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/34998380/ |
|---|
